References
- Rossi GP. A comprehensive review of the clinical aspects of primary aldosteronism. Nat Rev Endocrinol 2011;7:485-495. https://doi.org/10.1038/nrendo.2011.76
- Dougados M, Baeten D. Spondyloarthritis. Lancet 2011; 377:2127-2137. https://doi.org/10.1016/S0140-6736(11)60071-8
- Herrada AA, Campino C, Amador CA, Michea LF, Fardella CE, Kalergis AM. Aldosterone as a modulator of immunity: implications in the organ damage. J Hypertens 2011;29:1684-1692. https://doi.org/10.1097/HJH.0b013e32834a4c75
- Tanaka M, Izeki M, Miyazaki Y, et al. Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated by Hashimoto's thyroiditis. Intern Med 2002;41:967-971. https://doi.org/10.2169/internalmedicine.41.967
- Krysiak R, Okopien B. Coexistence of primary aldosteronism and Hashimoto's thyroiditis. Rheumatol Int 2012;32:2561-2563. https://doi.org/10.1007/s00296-011-2032-6
Cited by
- Coexistence of Primary Hyperaldosteronism and Graves' Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence—A Case Report and Review of the Literature vol.2017, pp.None, 2017, https://doi.org/10.1155/2017/4050458